Efficacy of Sotrastaurin Plus Tacrolimus AfterDe NovoKidney Transplantation: Randomized, Phase II Trial Results-Reference-Cited by-同舟云学术

Efficacy of Sotrastaurin Plus Tacrolimus AfterDe NovoKidney Transplantation: Randomized, Phase II Trial Results

Published:2013-05-13 Issue:7 Volume:13 Page:1746-1756
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Russ G. R.¹,Tedesco-Silva H.²,Kuypers D. R.³,Cohney S.⁴,Langer R. M.⁵,Witzke O.⁶,Eris J.⁷,Sommerer C.⁸,von Zur-Mühlen B.⁹,Woodle E. S.¹⁰,Gill J.¹¹,Ng J.¹²,Klupp J.¹³,Chodoff L.¹²,Budde K.¹⁴

Affiliation:

1. Department of Nephrology and Transplantation, Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Faculty of Health Sciences; University of Adelaide, North Terrace; Adelaide, SA; Australia

2. Division of Nephrology; Hospital do Rim e Hipertensão-UNIFESP; São Paulo; Brazil

3. Department of Nephrology and Renal Transplantation; University Hospitals of Leuven; Leuven; Belgium

4. Royal Melbourne Hospital; Department of Nephrology; Melbourne, VIC; Australia

5. Department of Transplantation and Surgery; Semmelweis University; Budapest; Hungary

6. Department of Nephrology; University Duisburg-Essen; Essen; Germany

7. Royal Prince Alfred Hospital; Camperdown, NSW; Australia

8. Department of Nephrology; University Hospital Heidelberg; Heidelberg; Germany

9. Transplantationskirurgiska Enh; Akademiska Sjukhuset; Uppsala; Sweden

10. Department of Surgery, Surgery/Transplant Division; University of Cincinnati; Cincinnati, OH

11. St. Paul's Hospital; Vancouver; Canada

12. Novartis Pharmaceuticals Corporation; East Hanover, NJ

13. Novartis Pharma AG; Basel; Switzerland

14. Department of Nephrology; Charité Universitätsmedizin Berlin; Berlin; Germany

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference17 articles.

1. Long-term kidney allograft function and survival in prednisone-free regimens: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus;Chhabra;Clin J Am Soc Nephrol,2012

2. Immunosuppression: Evolution in practice and trends, 1994-2004;Meier-Kriesche;Am J Transplant,2006

3. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future;de Mattos;Am J Kidney Dis,2000

4. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus;Vincenti;Am J Transplant,2007

5. Nephrotoxicity of immunosuppressive drugs: New insight and preventive strategies;Olyaei;Curr Opin Crit Care,2001

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

2. New immunosuppressive agents in transplantation;La Presse Médicale;2022-12

3. Early Medical and Surgical Complications After Kidney Transplantation;Evidence‐Based Nephrology;2022-11-18

4. Nouvelles stratégies immunosuppressives en transplantation;Bulletin de l'Académie Nationale de Médecine;2022-04

5. Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;Annals of Transplantation;2021-12-14